Comparison of 7-day PPI-based Standard Triple Therapy and 10-day Bismuth Quadruple Therapy for H. Pylori Eradication
Status:
Completed
Trial end date:
2019-09-28
Target enrollment:
Participant gender:
Summary
In this randomized controlled trial, we investigate the effect of 10-day bismuth quadruple
therapy in comparison with that of 7-day PPI-based standard triple as 1st line treatment for
H. pylori.